Mejores países para el tratamiento de Síndrome de la salida torácica en el mundo

Spain excels in treating thoracic outlet syndrome through specialized multidisciplinary centers in Madrid and Barcelona. These facilities combine vascular, neurological, and thoracic expertise to address nerve and vessel compression. Fast diagnostic imaging and access to robotic-assisted decompression help patients resolve complex symptoms quickly.

• Specialized surgical hubs: Centers like Hospital Ruber Internacional treat 25,000+ patients annually with focused neurological expertise.
• Expert clinical leadership: Dr. Rafael Arroyo González leads neurology departments and has managed 100+ clinical trials.
• High-standard accreditation: Spanish hospitals maintain JCI and ISO certifications to ensure rigorous international patient safety.
• Advanced diagnostic precision: Neurologists like Dr. Oriol Franch specialize in second opinions and complex neuromuscular diagnostics.

Bookimed Expert Insight: Spain's private neurology network is highly concentrated in Madrid and Barcelona. Top clinics often share specialists, like Dr. Rafael Arroyo González, who manages multiple departments. This concentration allows for faster coordination between neurosurgeons and vascular specialists than in other European countries.

What patients say: Patients note that Spanish vascular surgeons diagnose mystery symptoms faster than doctors elsewhere. They report quick recovery within 4 weeks and emphasize the value of excellent physiotherapy follow-up in Barcelona. Those treated describe feeling immense gratitude after years of searching for answers.

Turquía es reconocida por sus tratamientos avanzados del síndrome de la salida torácica (SST), con hospitales acreditados como Memorial Antalya, Şişli y Ataşehir a la cabeza. Estos centros, que forman parte del Memorial Healthcare Group, están acreditados por la JCI, lo que garantiza un alto nivel asistencial. Memorial Antalya destaca en cirugía general y reconstructiva, mientras que Şişli ofrece un enfoque multidisciplinar, tratando anualmente a pacientes de 92 países. Ataşehir tiene unas tasas de éxito del 99,5% en trasplantes de hígado y del 99% en trasplantes de riñón.

Los tratamientos innovadores del TOS en Turquía incluyen cirugía de descompresión mínimamente invasiva, procedimientos asistidos por robot e intervenciones endovasculares, que contribuyen a las altas tasas de éxito. Una revisión sistemática destaca el papel de los tratamientos físicos en la reducción de los síntomas y la mejora de los resultados.